Moderna stock could be at risk as uncertainty over Covid-19 vaccine demand looms over the winter season, according to TD Cowen.
TD Cowen is taking a step back on Moderna . The firm downgraded shares in the vaccine provider to market perform from outperform and lowered its price target to $125 from $145. TD Cowen's forecast implies roughly 14% upside from Thursday's $109.95 close.
mountain Moderna stock has dipped nearly 40% from the start of the year. — CNBC's Michael Bloom contributed to this report.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna shares rise on better Covid vaccine outlook despite sharp drop in salesModerna and its rivals Pfizer and Novavax have all seen a steep drop in sales of Covid vaccines and treatments as the world moves on from the pandemic.
Weiterlesen »
Moderna or Pfizer? One COVID Shot May Be Safer for Older AdultsWhile both the Moderna and Pfizer COVID-19 vaccines are considered safe and highly effective, new research finds the Moderna shot has been the safest and most effective for seniors.
Weiterlesen »
COVID ‘surge,’ COVID ‘uptick’ and leprosy — and so it beginsHeadlines are ablaze with alerts about a summertime COVID-19 “uptick,” and worse, a summertime COVID-19 “surge,” and as the medical experts everywhere are advising: Keep a face mask handy; stay on the COVID-19 shot schedule; listen up for lockdowns. Hmm. An important election must be coming.
Weiterlesen »
There May Be Another Covid Surge Happening in DC - WashingtonianWhile numbers are still low, Covid experts predict that we will continue to see waves of infection.
Weiterlesen »
The COVID origins disinformation operation has obliterated trust in our institutionsAndrew Rambaut, evolutionary biologist and co-author of the highly influential essay “The Proximal Origin of SARS-CoV-2,” which purportedly “debunked” the lab leak theory of COVID’s origin in March 2020, wrote the following to a fellow co-author a month before its release:
Weiterlesen »